Drug recall
Neo-Sulfalyte, neomycin/sulfamethazine/electrolyte bolus, each bolus contains 250-mg. neomycin, 2,000-mg…
FDA recall event 48450 · Class II · Pfizer Inc. Of Canada
Key facts
| Event ID | 48450 |
|---|---|
| Recall numbers | V-211-2008 |
| Recalling firm | Pfizer Inc. Of Canada |
| Product type | Veterinary |
| Products | Neo-Sulfalyte, neomycin/sulfamethazine/electrolyte bolus, each bolus contains 250-mg. neomycin, 2,000-mg. sulfamethazine, 38-mg. potassium acetate, 11-mg. magnesium chloride hexahydrate, 11-mg… |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | OOS for neomycin potency (low) |
| Initiation date | May 30, 2008 |
| Termination date | Jan 28, 2010 |
| City | Kirkland |
| Country | Canada |
| FEI number | 3001970377 |
At a glance
- 1–9 Products in this recall
- None FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports